Valuation: Balchem Corporation

Market Cap 542.35Cr 473.91Cr 435.18Cr 405.83Cr 769.36Cr 52TCr 782.34Cr 5.24TCr 2.03TCr 25TCr 2.04TCr 1.99TCr 87TCr P/E 2026 *
32.2x
P/E 2027 * 30.6x
Enterprise Value 545.55Cr 476.7Cr 437.74Cr 408.22Cr 773.89Cr 52TCr 786.95Cr 5.27TCr 2.04TCr 25TCr 2.05TCr 2TCr 88TCr EV / Sales 2026 *
4.93x
EV / Sales 2027 * 4.62x
Free-Float
99.53%
Yield 2026 *
0.67%
Yield 2027 * 0.75%
1 day-0.05%
1 week-0.25%
Current month-0.09%
1 month+7.30%
3 months-0.95%
6 months+9.60%
Current year+10.07%
1 week 167.05
Extreme 167.05
171.86
1 month 155.87
Extreme 155.87
174.09
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 59.07
Extreme 59.07
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap.
01/04Other

Controller/Auditor

8,646 0.0270%
11/02Free

Head of Human Resources

8,685 0.0268%
11/02Free

Chief Executive Officer

62,743 0.1937%
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%-0.25%+3.43%+25.21% 542.35Cr
+1.79%+0.77%+4.00%+51.78% 7.97TCr
-0.31%+2.89%-9.89%+18.02% 4.03TCr
+0.69%+3.52%-17.66%-31.23% 3.45TCr
+3.04%+5.38%+16.73%+24.80% 2.61TCr
-2.05%-0.56%+94.18%+0.11% 2.08TCr
+0.14%-0.50%+12.54%+3.04% 2.03TCr
+1.04%+1.53%-36.07%-34.72% 1.89TCr
-0.26%-3.89%+99.38%-39.24% 1.6TCr
+0.13%+3.02%-0.94%-4.66% 1.43TCr
Average +0.42%+0.17%+16.57%+1.31% 2.76TCr
Weighted average by Cap. +0.77%+0.80%+10.39%+11.85%

Financials

2026 *2027 *
Net sales 110.64Cr 97Cr 89Cr 83Cr 156.95Cr 11TCr 159.6Cr 1.07TCr 414.24Cr 5.17TCr 415.42Cr 406.4Cr 18TCr 116.5Cr 101.79Cr 93Cr 87Cr 165.26Cr 11TCr 168.04Cr 1.13TCr 436.17Cr 5.44TCr 437.42Cr 427.91Cr 19TCr
Net income 17Cr 15Cr 14Cr 13Cr 24Cr 1.61TCr 24Cr 163.89Cr 64Cr 792.11Cr 64Cr 62Cr 2.73TCr 18Cr 16Cr 14Cr 13Cr 25Cr 1.7TCr 26Cr 172.53Cr 67Cr 833.91Cr 67Cr 66Cr 2.87TCr
Net Debt 3.2Cr 2.79Cr 2.57Cr 2.39Cr 4.54Cr 304.42Cr 4.61Cr 31Cr 12Cr 149.32Cr 12Cr 12Cr 514.5Cr -4.03Cr -3.52Cr -3.23Cr -3.01Cr -5.71Cr -383.29Cr -5.81Cr -39Cr -15Cr -188Cr -15Cr -15Cr -647.8Cr
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,368
Date Price Change Volume
02/26/02 $168.80 -0.05% 1,96,057
01/26/01 $168.89 -0.04% 2,17,541
30/26/30 $168.95 -0.15% 4,91,374
29/26/29 $169.21 -1.17% 2,63,560
26/26/26 $171.22 +1.18% 7,61,793
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
168.80USD
Average target price
200.75USD
Spread / Average Target
+18.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock